Immunotherapeutic Approaches in Malignant Pleural Mesothelioma

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) have emerged as a very promising therapeutic option for the treatment of many difficult-to-treat cancers and a number of clinical trials have explored their efficacy in malignant pleural mesothelioma patients. ICIs were initially evaluated in the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Terenziani, Rita, Zoppi, Silvia, Fumarola, Claudia, Alfieri, Roberta, Bonelli, Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200040/
https://www.ncbi.nlm.nih.gov/pubmed/34199722
http://dx.doi.org/10.3390/cancers13112793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200040/
https://www.ncbi.nlm.nih.gov/pubmed/34199722
http://dx.doi.org/10.3390/cancers13112793

Ejemplares similares